← Return to Clinical trials for Brain cancer (Glioblastomas or GBM)

Discussion

Clinical trials for Brain cancer (Glioblastomas or GBM)

Brain Tumor | Last Active: Apr 4 2:36pm | Replies (10)
Comment receiving replies
@kafiedler

These are all old posts. What about The imaging incorporated the use of 18F-DOPA PET and contrast-enhanced MRI. "18F-DOPA PET is an amino acid tracer that can cross the blood brain barrier, and it can accumulate within the glioblastoma cells itself," says Dr. Vora.

Is this available now as a treatment? Is the study completed? Mayo will not talk to us about this. You have to go there and be diagnosed and treated by them. They won't even say what the criteria is for being accepted for consideration.

Jump to this post

Replies to "These are all old posts. What about The imaging incorporated the use of 18F-DOPA PET and..."
Colleen Young, Connect Director | @colleenyoung | Apr 4 2:36pm

@kafiedler, it appears that recruitment for phase 2 of the study is currently closed. See more information here:
- The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma https://www.mayo.edu/research/clinical-trials/cls-20366131

If you'd like to find out more about the next steps of this study (phase 3), you can contact the study coordinator 855-776-0015 (toll-free)

Here is information about the results of the phase 2 study.
- Mayo Clinic study offers hope for patients with glioblastoma https://connect.mayoclinic.org/blog/health-equity-research/newsfeed-post/mayo-clinic-study-offers-hope-for-glioblastoma-patients-a-deadly-type-of-brain-cancer/

VIEW AND REPLY